NVS Summary

  1. NYSE
  2. >
  3. NVS
TickerNVS
DescriptionNOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD)
Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
ExchangeNYSE
TypeStock
SectorHealthcare
Employees103,914
Next Earnings DateOctober 27th, 2020
IV25.150632%
IV Percentile77th
IV Rank22.79%
IV Skew9.033231
IV Skew Percentile41st
IV Skew SentimentNeutral
Option Volume952
Volume810,594
Price$84.43
Previous Close$84.41
52-Week High$99.8429
52-Week Low$69.1801
50-Day Moving Avg.$87.26
200-Day Moving Avg.$87.13
10-Day Avg. Volume1,472,399
20-Day Avg. Volume1,683,408
30-Day Avg. Volume1,822,926
3-Month Avg. Volume1,750,753
PE26.79618
EPS$3.14
Outstanding Shares2,204,693,668
Float2,204,691,463
Market Capitalization$207,578,505,800
CurrencyUSD
UpdatedOctober 23rd, 2020